TYRVAYA

Peak

varenicline

NDANASALSPRAY
Approved
Oct 2021
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20

Clinical Trials (5)

NCT03722966Phase 2Terminated

Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)

Started Jan 2020
34 enrolled
Smoking Cessation
NCT04083144N/ACompleted

Deep rTMS and Varenicline for Smoking Cessation

Started Aug 2019
50 enrolled
Tobacco Use DisorderSmoking Cessation
NCT03365362Phase 4Completed

A Trial of Directly Observed and Long-term Varenicline

Started Oct 2018
243 enrolled
Tobacco Use DisorderOpioid-use Disorder
NCT03557294Phase 4Completed

Varenicline OTC Trial on Efficacy and Safety

Started May 2018
313 enrolled
Tobacco DependenceWithdrawal SymptomsSmoking Cessation
NCT02859142Phase 4Completed

Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation

Started Mar 2018
122 enrolled
Smoking CessationAlcohol Drinking

Loss of Exclusivity

LOE Date
Oct 19, 2035
117 months away
Patent Expiry
Oct 19, 2035

Patent Records (5)

Patent #ExpiryTypeUse Code
10456396
Oct 19, 2035
Product
U-1900
11224598
Oct 19, 2035
U-1900
11903941
Oct 19, 2035
U-1900
11903942
Oct 19, 2035
Product
11903943
Oct 19, 2035
U-1900